The latest price target for Affimed (NASDAQ:AFMD) was reported by Cantor Fitzgerald on November 19, 2024. The analyst firm set a price target for $0.00 expecting AFMD to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.

The latest analyst rating for Affimed (NASDAQ:AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

There is no last upgrade for Affimed

The last downgrade for Affimed NV happened on October 10, 2022 when Stifel changed their price target from $9 to $2 for Affimed NV.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on November 19, 2024 so you should expect the next rating to be made available sometime around November 19, 2025.

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $0.00. The current price Affimed (AFMD) is trading at is $2.75, which is out of the analyst’s predicted range.